Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Senti Biosciences, Inc. - Common Stock (NQ: SNTI ) 2.250 -0.070 (-3.02%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Senti Biosciences, Inc. - Common Stock < Previous 1 2 3 4 Next > 12 Health Care Stocks Moving In Thursday's Pre-Market Session July 04, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 02, 2024 Pre-market stock movers are worth diving into this morning as we break down all of the biggest news moving shares on Tuesday! Via InvestorPlace Senti Biosciences (SNTI) Stock Is Up Over 100%: What's Happening? July 01, 2024 Senti Biosciences shares are trading higher by 102.6% during Monday's session. The company was awarded $8 million from the California Institute for Regenerative Medicines. Via Benzinga Why Is Beyond Air (XAIR) Stock Down 22% Today? June 25, 2024 Beyond Air stock is down on Tuesday as investors in XAIR react to the company mixed earnings report for the first quarter of the year. Via InvestorPlace SNTI Stock Earnings: Senti Biosciences Reported Results for Q1 2024 May 09, 2024 Senti Biosciences just reported results for the first quarter of 2024. Via InvestorPlace Why Is Faraday Future (FFIE) Stock Down 27% Today? June 25, 2024 Faraday Future stock is down on Tuesday after the troubled EV company announced plans for a reverse split of FFIE shares. Via InvestorPlace Why Is Senti Biosciences (SNTI) Stock Up 32% Today? June 25, 2024 Senti Biosciences stock is up on Tuesday with heavy pre-market trading of SNTI shares despite a lack of news from the company. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 25, 2024 Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning! Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session June 07, 2024 Via Benzinga SNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023 March 21, 2024 SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session January 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session January 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session December 25, 2023 Via Benzinga Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today? December 22, 2023 Senti Biosciences Inc (NASDAQ: SNTI) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, an off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cell... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Friday's Pre-Market Session December 22, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session December 18, 2023 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session December 12, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday December 12, 2023 Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session December 07, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 16, 2023 It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday! Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session November 13, 2023 Via Benzinga Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal November 11, 2023 Eccogene, a Shanghai-Boston biotech, out-licensed global rights (ex-China) for its novel small molecule GLP-1 agonist to AstraZeneca in a $2 billion blockbuster deal. Eccogene will receive $185 million... Via Talk Markets 12 Health Care Stocks Moving In Wednesday's Intraday Session November 08, 2023 Via Benzinga Crude Oil Falls Sharply; Datadog Shares Spike Higher November 07, 2023 U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up 0.21% to 34,166.89 while the NASDAQ rose 1.09% to 13,666.65. The S&P 500... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session November 07, 2023 Via Benzinga Nasdaq Jumps 100 Points; US Trade Deficit Widens In September November 07, 2023 U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow traded up 0.19% to 34,159.14 while the NASDAQ rose 0.84% to 13,631.99. The... Via Benzinga Topics Stocks Exposures US Equities Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 07, 2023 Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. Via Benzinga US Stocks Mixed; D.R. Horton Earnings Top Views November 07, 2023 U.S. stocks traded mixed this morning, with the Dow Jones falling around 50 points on Tuesday Following the market opening Tuesday, the Dow traded down 0.18% to 34,035.79 while the NASDAQ rose 0.14% to... Via Benzinga Topics Stocks Exposures US Equities Why Is Cell & Gene Therapy-Focused Senti Biosciences Stock Trading Higher Today? November 07, 2023 Senti Biosciences Inc (NASDAQ: SNTI) announced a new strategic collaboration with Celest Therapeutics (Shanghai) Co Ltd, a China-based biotechnology company, for the clinical development of SENTI-301A... Via Benzinga Why Is Alto Ingredients (ALTO) Stock Down 45% Today? November 07, 2023 Alto Ingredients stock is falling on Tuesday after the company released a mixed earnings report for the third quarter of the year. Via InvestorPlace < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.